European approval for diabetes drug canaglifozin expected (Diabetes.co.uk, 25 September 2013)

26 Sept 2013

Europeans suffering from type 2 diabetes may soon be given a new oral drug treatment option called canagliflozin, which helps reduce blood glucose levels by preventing the reabsorption of glucose from the kidneys back into the blood so that more glucose is excreted in the urine.